EMD Group LLC

EMD Group LLC, a Georgia-based limited liability company, supplies laboratory equipment, diagnostic reagents, and medical instruments to the Department of Defense and Defense Health Agency as a prime contractor on low-dollar purchase orders, with no set-aside designation and 100% of recent awards fully obligated.

The vendor operates exclusively as a prime and carries no federal subcontracting footprint. EMD Group LLC holds three prime purchase orders issued between July 7 and July 20, 2026, totaling $179 thousand in combined potential value. The Defense Health Agency accounts for two awards ($135 thousand combined potential value): a $111.2 thousand purchase order for MiSeq and DeepChek reagents, DNA preparation kits, viral surveillance panels, PhiX controls, and HIV-1 genotyping assay kits with staggered delivery across August 2026, September 2026, December 2026, and June 2027; and a $24 thousand order for a PCR device with completion by August 20, 2026. The Defense Advanced Research Projects Agency issued a single $43.5 thousand purchase order for laboratory supplies supporting the U.S. Embassy Tbilisi WRAIR office, with ultimate completion July 30, 2027. All work is performed in Georgia and derives from RFQ solicitations issued in June 2026.

EMD Group LLC's federal award activity is nascent. No awards predate 2026, and the three-award footprint represents initial federal market entry with specialized diagnostic and molecular biology supplies. Two awards ($155 thousand combined potential value) reach ultimate completion within the next twenty-four months, representing the entirety of the visible near-term recompete exposure. The vendor operates under NAICS 423490 (analytical laboratory instrument wholesaling) and PSC 6640 (laboratory equipment and supplies), with secondary classification under PSC 4210 (medical and surgical instruments, equipment, and supplies) for reagent and device work. The vendor competes full-and-open with no SBA set-aside certifications recorded in the source data.